Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 13 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors at 5 institutions in 6 countries.
Wenzheng ZhangChongqing Key Laboratory of Natural Product Synthesis and Drug Research Innovative Drug Research Center School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, P. R. China.ORCID http://orcid.org/0000-0001-5292-2443
Dinesh DhumalCentre Interdisciplinaire de Nanoscience de Marseille (CINaM) UMR 7325, Equipe Labellisé par La Ligue, Aix-Marseille Université, CNRS, Marseille, 13288, France.
Xiaolei ZhuCentre Interdisciplinaire de Nanoscience de Marseille (CINaM) UMR 7325, Equipe Labellisé par La Ligue, Aix-Marseille Université, CNRS, Marseille, 13288, France.
Brigino RalahyCentre Interdisciplinaire de Nanoscience de Marseille (CINaM) UMR 7325, Equipe Labellisé par La Ligue, Aix-Marseille Université, CNRS, Marseille, 13288, France.
Aleksandra Ellert-MiklaszewskaLaboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, 02-093, Poland.ORCID http://orcid.org/0000-0002-7947-5660
Jing WuCentre Interdisciplinaire de Nanoscience de Marseille (CINaM) UMR 7325, Equipe Labellisé par La Ligue, Aix-Marseille Université, CNRS, Marseille, 13288, France.
Erik LauriniMolecular Biology and Nanotechnology (MolBNL@UniTS) Laboratory DEA, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy.
Yi-Wen YaoCentre Interdisciplinaire de Nanoscience de Marseille (CINaM) UMR 7325, Equipe Labellisé par La Ligue, Aix-Marseille Université, CNRS, Marseille, 13288, France.ORCID http://orcid.org/0000-0001-5490-9509
Chai-Lin KaoDepartment of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Juan L IovannaCentre de Recherche en Cancérologie de Marseille (CRCM) INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Marseille, 13288, France.
Sabrina PriclMolecular Biology and Nanotechnology (MolBNL@UniTS) Laboratory DEA, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy.ORCID http://orcid.org/0000-0001-8380-4474
Bozena KaminskaLaboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, 02-093, Poland.ORCID http://orcid.org/0000-0002-2642-4616
Yi XiaChongqing Key Laboratory of Natural Product Synthesis and Drug Research Innovative Drug Research Center School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, P. R. China.ORCID http://orcid.org/0000-0001-5863-7272
Ling PengCentre Interdisciplinaire de Nanoscience de Marseille (CINaM) UMR 7325, Equipe Labellisé par La Ligue, Aix-Marseille Université, CNRS, Marseille, 13288, France.ORCID http://orcid.org/0000-0003-3990-5248
Centre National de la Recherche Scientifique · FRInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Trieste · ITChongqing University · CNKaohsiung Medical University · TW
Funding
Bourse d'Excellence Eiffel Y-WYBourses d'excellence PACA Y-WYCampus France PHC CAI YUAN PEI program YX, JLIChina Scholarship Council WZEU H2020 Research and Innovation program NMBP "SAFE-N-MEDTECH" (2019-2023) 814607French National Research Agency and the National Centre for Research and Development in Poland under the frame of H2020 Era-Net EURONANOMED European Research project 'iNANOGUN' LP, BKFrench National Research Agency and the National Centre for Research and Development in Poland under the frame of H2020 Era-Net EURONANOMED European Research project 'NAN4TUM' LP, C-LKFrench National Research Agency and the National Centre for Research and Development in Poland under the frame of H2020 Era-Net EURONANOMED European Research project 'NANOGLIO' LP, BKGraduate Research and Innovation Foundation of Chongqing CYB19066, WZH2020 Marie Skłodowska-Curie Innovative Training Network "OLIGOMED" (2021-2024) 956070Italian Association for Cancer Research (IG17413) SPLigue Nationale Contre le Cancer EL2021 LNCCLiP, LPMinistry of Education of Taiwan Scholarship for Excellent Students to Study Abroad or Overseas Internship Training Y-WYMinistry of Science and Technology of Taiwan 109-2923-M-037-001-MY3National Natural Science Foundation of China 81502920, YXOrchid program LP,C-LK
6 · The paper itself
Abstract
Dendrimers are appealing scaffolds for creating carbohydrate mimics with unique multivalent cooperativity. We report here novel bola-amphiphilic glycodendrimers bearing mannose and glucose terminals, and a hydrophobic thioacetal core responsive to reactive oxygen species. The peculiar bola-amphiphilic feature enabled stronger binding to lectin compared to conventional amphiphiles. In addition, these dendrimers are able to target mannose receptors and glucose transporters expressed at the surface of cells, thus allowing effective and specific cellular uptake. This highlights their great promise for targeted delivery.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bola-Amphiphilic Glycodendrimers: New Carbohydrate-Mimicking Scaffolds to Target Carbohydrate-Binding Proteins. · full record | OpenQuestion